These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12422288)

  • 41. Epidemiology of complementary alternative medicine for asthma and allergy in Europe and Germany.
    Schäfer T
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2 Suppl 1):S5-10. PubMed ID: 15330007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementary and alternative medicine costs - a systematic literature review.
    Maxion-Bergemann S; Wolf M; Bornhöft G; Matthiessen PF; Wolf U
    Forsch Komplementmed; 2006; 13 Suppl 2():42-5. PubMed ID: 16883079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complementary medicine at Exeter: the first 10 years.
    Kanji N; Huntley A
    Complement Ther Nurs Midwifery; 2004 May; 10(2):110-5. PubMed ID: 15135763
    [No Abstract]   [Full Text] [Related]  

  • 44. Review article: complementary and alternative therapies for inflammatory bowel disease.
    Langmead L; Rampton DS
    Aliment Pharmacol Ther; 2006 Feb; 23(3):341-9. PubMed ID: 16422993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Does the study "Complementary medicine in health insurance" provide a basis for scientifically valid conclusions?].
    Kienle GS; Kiene H
    Forsch Komplementarmed; 1999 Oct; 6(5):262-70. PubMed ID: 10575280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health economic studies on complementary and integrative medicine.
    Witt CM
    Forsch Komplementmed; 2011; 18(1):6-9. PubMed ID: 21372581
    [No Abstract]   [Full Text] [Related]  

  • 47. Complementary therapies: what is the evidence for their use?
    Richardson J; Jones C; Pilkington K
    Prof Nurse; 2001 Oct; 17(2):96-9. PubMed ID: 12030073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 'It couldn't hurt .... Could it?' Safety of complementary and alternative medicine practices.
    Kruskal B
    Acta Paediatr; 2009 Apr; 98(4):628-30. PubMed ID: 19290964
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of Swiss basic health insurance costs of complementary and conventional medicine.
    Studer HP; Busato A
    Forsch Komplementmed; 2011; 18(6):315-20. PubMed ID: 22189362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complementary Medicine - a critical analysis].
    Ernst E
    Wien Med Wochenschr; 2008; 158(7-8):218-21. PubMed ID: 18500475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials.
    Turner LA; Singh K; Garritty C; Tsertsvadze A; Manheimer E; Wieland LS; Galipeau J; Moher D
    BMC Complement Altern Med; 2011 Aug; 11():67. PubMed ID: 21859470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complementary and alternative medicine in outcomes research.
    Riley D; Berman B
    Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498
    [No Abstract]   [Full Text] [Related]  

  • 53. Alternative therapies for asthma: are patients at risk?
    Thomas M; Lewith G
    Clin Med (Lond); 2013 Feb; 13(1):113. PubMed ID: 23472511
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of randomized control trials in complementary therapies: exploring the issues.
    Richardson J
    J Adv Nurs; 2000 Aug; 32(2):398-406. PubMed ID: 10964188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of costs for complementary medicine after provisional inclusion into the Swiss basic health insurance.
    Studer HP; Busato A
    Forsch Komplementmed; 2011; 18(1):15-23. PubMed ID: 21372583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population.
    de Asis ML; Greene R
    J Asthma; 2004 Aug; 41(5):559-65. PubMed ID: 15360065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alternative medicine--a true alternative or only another market?].
    Ziegenhagen DJ
    Versicherungsmedizin; 1996 Apr; 48(2):33-5. PubMed ID: 8659048
    [No Abstract]   [Full Text] [Related]  

  • 58. Complementary and alternative medicine. Part 2--evidence and implications for GPs.
    Kotsirilos V
    Aust Fam Physician; 2005 Aug; 34(8):689-91. PubMed ID: 16113710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating complementary medicine: methodological challenges of randomised controlled trials.
    Mason S; Tovey P; Long AF
    BMJ; 2002 Oct; 325(7368):832-4. PubMed ID: 12376448
    [No Abstract]   [Full Text] [Related]  

  • 60. [Complementary medicine: is proof of effectiveness really necessary?].
    Ernst E
    Versicherungsmedizin; 2006 Mar; 58(1):1-2. PubMed ID: 16553218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.